US Patent Issued to BOUNDLESS BIO on Jan. 20 for "Checkpoint kinase 1 (CHK1) inhibitors and uses thereof" (California Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,790, issued on Jan. 20, was assigned to BOUNDLESS BIO INC. (San Diego).

"Checkpoint kinase 1 (CHK1) inhibitors and uses thereof" was invented by Anthony B. Pinkerton (Rancho Santa Fe, Calif.), Stephen Todd Meyer (San Diego), Jacques Mauger (San Diego), Yen Pham Hong Truong (San Diego) and Rachelle Janette Elsdon (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compounds and methods for the treatment of cancer. The methods include administering to a subject in need a therapeutically effective amount of a Chk1 inhibitor disclosed herein."

The patent was filed on June 1, 2023, under Application No. 18/327,775.

*For furthe...